ADVERTISEMENT
ADVERTISEMENT
Jeeva Clinical Trials launches AI program for academic centers
The initiative will provide universities with AI-driven tools, training, and support for investigator-led studies.
-
1759953093.png)
Staff Reporter - Mon, 20, Apr 2026
- 18:03 EDT
- 25
Jeeva Clinical Trials Academic Partnership Program / Jeeva Clinical Trials
Virginia-based Jeeva Clinical Trials has launched a new initiative aimed at equipping researchers, physicians, and trainees with AI-enabled tools and modern clinical trial capabilities.
The Academic Medical Center (AMC) Partnership Program will provide selected institutions with access to AI-enabled clinical trial tools, training workshops, and support for investigator-led studies, the company said.
Also Read: UPenn's Rahul Mangharam advances Swarm AI for real world interactions
According to the company, academic medical centers, which combine patient care, research, and education, remain central to developing advanced treatments such as cell and gene therapies and immunotherapies. However, institutions are under increasing pressure from complex multi-site trials, administrative burden, and limited access to modern digital infrastructure.
At the same time, clinical trials have shifted toward decentralized and hybrid models that rely on electronic consent systems, remote patient monitoring, and real-time data tools—areas where many training programs have not kept pace.
Elaborting on the significance of the new initiative, Harsha K. Rajasimha, CEO of Jeeva Clinical Trials, said the program is intended to align training environments with current industry practices.
“Academic medical centers occupy a uniquely powerful and uniquely demanding position in our healthcare system… the technology powering the next generation of clinical trials should be in the hands of the people training that next generation,” he said.
Experts said closer coordination between academia and industry is becoming necessary as clinical research grows more technology-dependent.
“As clinical research evolves, partnerships between academia and industry are increasingly important to bring infrastructure, technology, and expertise together in ways that can improve study efficiency and broaden patient access,” said Sona Vasudevan of Georgetown University Medical Center.
Dr. Siddhartha Sikdar of George Mason University said such collaboration is particularly important for institutions building research capacity outside traditional academic medical centers.
Jeeva said its platform integrates functions such as electronic consent, patient-reported outcomes, remote monitoring, and regulatory workflows into a single system aimed at reducing fragmentation in trial operations.
Under the program, participating institutions will receive training on decentralized trial design, AI applications in research, and regulatory requirements, along with hands-on access to the company’s platform. The initiative also includes collaboration opportunities and support for investigator-initiated studies.
As part of the rollout, thecompany said it has already conducted workshops at five U.S. academic institutions focused on AI in decentralized and hybrid trials.
Discover more at New India Abroad.
Related
ADVERTISEMENT
ADVERTISEMENT
E Paper
Video
Comments
Start the conversation
Become a member of New India Abroad to start commenting.
Sign Up Now
Already have an account? Login